JP2015517306A5 - - Google Patents

Download PDF

Info

Publication number
JP2015517306A5
JP2015517306A5 JP2015510828A JP2015510828A JP2015517306A5 JP 2015517306 A5 JP2015517306 A5 JP 2015517306A5 JP 2015510828 A JP2015510828 A JP 2015510828A JP 2015510828 A JP2015510828 A JP 2015510828A JP 2015517306 A5 JP2015517306 A5 JP 2015517306A5
Authority
JP
Japan
Prior art keywords
ionic strength
low ionic
monoclonal antibody
composition
strength buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015510828A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015517306A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/059696 external-priority patent/WO2013167720A1/en
Publication of JP2015517306A publication Critical patent/JP2015517306A/ja
Publication of JP2015517306A5 publication Critical patent/JP2015517306A5/ja
Pending legal-status Critical Current

Links

JP2015510828A 2012-05-11 2013-05-10 モノクローナル抗体の精製のための結晶化方法 Pending JP2015517306A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261645855P 2012-05-11 2012-05-11
US61/645,855 2012-05-11
PCT/EP2013/059696 WO2013167720A1 (en) 2012-05-11 2013-05-10 Crystallization methods for purification of monoclonal antibodies

Publications (2)

Publication Number Publication Date
JP2015517306A JP2015517306A (ja) 2015-06-22
JP2015517306A5 true JP2015517306A5 (enExample) 2016-06-30

Family

ID=48326319

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015510828A Pending JP2015517306A (ja) 2012-05-11 2013-05-10 モノクローナル抗体の精製のための結晶化方法

Country Status (14)

Country Link
US (2) US20150133642A1 (enExample)
EP (1) EP2846830A1 (enExample)
JP (1) JP2015517306A (enExample)
KR (1) KR20150016503A (enExample)
CN (1) CN104284676B (enExample)
AU (1) AU2013258006B2 (enExample)
BR (1) BR112014027994A2 (enExample)
CA (1) CA2872145A1 (enExample)
IL (1) IL235483A0 (enExample)
IN (1) IN2014DN09097A (enExample)
MX (1) MX2014013754A (enExample)
RU (1) RU2014150071A (enExample)
SG (1) SG11201406664SA (enExample)
WO (1) WO2013167720A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3015542A1 (de) * 2015-05-07 2016-05-04 Bayer Technology Services GmbH Modulare anlage und verfahren zur kontinuierlichen, keimreduzierten produktion und/oder aufbereitung eines produktes
EP3858145A1 (en) * 2016-12-23 2021-08-04 Arla Foods amba Production of novel beta-lactoglobulin preparations and related methods, uses, and food products
JP7229933B2 (ja) * 2017-03-14 2023-02-28 アムジェン インコーポレイテッド 結晶性生体分子を対象にする方法
CA3104750A1 (en) 2018-06-27 2020-01-02 Arla Foods Amba Acidic beta-lactoglobulin beverage preparation
IT202100004496A1 (it) 2021-02-25 2022-08-25 Univ Della Calabria Recupero di farmaci biologici o loro frammenti da soluzioni impure mediante cristallizzazione o precipitazione con membrane
CN116949036B (zh) * 2023-09-11 2023-12-15 成都斯马特科技有限公司 一种快速从腹水中提取核酸的试剂盒及提取方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030074693A (ko) * 2000-12-28 2003-09-19 알투스 바이올로직스 인코포레이티드 전항체 및 이의 단편의 결정과 이의 제조 및 사용 방법
EP2322165A1 (en) * 2001-11-13 2011-05-18 Genentech, Inc. Apo2 ligand/TRAIL formulations
US7087719B2 (en) * 2002-11-19 2006-08-08 Gtc Biotherapeutics, Inc. Method for the crystallization of human serum albumin
BRPI0820604A2 (pt) * 2007-12-21 2017-05-09 Genentech Inc método de purificação de um anticorpo cd20, cristal de um anticorpo cd20, composição e método destinado ao tratamento de uma condição ou doença associada ao cd20
CN101320006B (zh) * 2008-07-17 2010-12-01 西北工业大学 蛋白质结晶条件的筛选方法

Similar Documents

Publication Publication Date Title
JP2015517306A5 (enExample)
RU2014150071A (ru) Способы кристаллизации для очистки моноклональных антител
EP4151645A3 (en) Separation of 2'-fl from a fermentation broth
CA2797356A1 (en) Improved cell culture medium
RU2013144731A (ru) СПОСОБ ПОЛУЧЕНИЯ КОМПОЗИЦИИ ЧАСТИЦ, СОДЕРЖАЩЕЙ БЕЗВОДНУЮ КРИСТАЛЛИЧЕСКУЮ 2-О-α-D-ГЛЮКОЗИЛ-L-АСКОРБИНОВУЮ КИСЛОТУ
JP2015532096A5 (enExample)
JP2016513478A5 (enExample)
CN107190140A (zh) 一种从离子吸附型稀土矿中回收稀土和铝的方法
MX2025000300A (es) Metodo para producir edulcorante cristalino funcional
US20150376228A1 (en) Process for high efficiency refolding of recombinant proteins
CN110114341B (zh) 使用结晶技术制备l-甲硫氨酸晶体的方法
CN114196611A (zh) 一种含有依克多因的缓冲稳定剂在制备原生质体中的应用
CN111961102B (zh) 5′-尿苷单磷酸晶体及其制备方法
CN103436591B (zh) 以盐类作为沉淀剂用于蛋白质结晶筛选的试剂盒
CN104030323B (zh) 一种盐湖提锂母液回收利用的盐田滩晒方法
CN107032371A (zh) 一种以萤石为原料制备氟化钾的方法
Palanisamy et al. Nucleation control and growth of metastable α-L-glutamic acid single crystals in the presence of L-phenylalanine
CN103755758B (zh) 一种制霉菌素的制备方法
CN103890230A (zh) 制造ZnMgO膜的方法
CN103898605B (zh) 一种用于锂电池材料的磷酸锂晶体的制备方法
CN113652456A (zh) 细胞重复利用生产普鲁兰多糖的方法及应用
CN103422114B (zh) 一种偏钒酸钾的制备方法
RU2011143444A (ru) Способ выращивания кристаллов галогенидов серебра и таллия
NZ603075A (en) Method for treating wastewater
KR20180134827A (ko) 결정화 기술을 이용한 l-메티오닌 결정의 제조방법